Sherwin-Williams
SHW
$310.55
+3.67%
The Sherwin-Williams Company is the world's largest manufacturer of paints and coatings, operating in the specialty chemicals industry. It is a dominant market leader with a vertically integrated model, distinguished by its vast network of over 4,800 company-owned stores which provide a significant competitive moat in serving professional painters and contractors. The current investor narrative revolves around the company's resilience and financial discipline as a Dividend Aristocrat, evidenced by its recent 47th consecutive annual dividend increase, while simultaneously navigating a challenging demand environment for housing and industrial end-markets that is pressuring top-line growth and investor sentiment.…
SHW
Sherwin-Williams
$310.55
Related headlines
Investment Opinion: Should I buy SHW Today?
Rating & Thesis: Hold. Sherwin-Williams is a high-quality company caught in a cyclical downturn; investors should wait for clearer signs of fundamental stabilization or a more compelling valuation before initiating or adding to positions. This aligns with the data showing a bullish analyst consensus but severe near-term price pressure.
Supporting Evidence: The stock trades at a forward P/E of 22.70x, a discount to its trailing multiple of 31.08x, implying expected earnings recovery. However, revenue growth decelerated to 5.64% in Q4, and profitability compressed sharply (Q4 net margin 8.52% vs. Q3 13.10%). The company's premium valuation metrics (P/S 3.39x, EV/EBITDA 21.42x) are high relative to typical specialty chemical peers, and the stock's technical posture is weak, trading near 52-week lows after a -17.15% annual decline.
Risks & Conditions: The two biggest risks are 1) further deterioration in housing/industrial demand leading to additional earnings misses, and 2) valuation multiple compression if the growth slowdown persists. This Hold rating would upgrade to a Buy if the forward P/E compresses further toward 18x-20x, or if quarterly revenue growth re-accelerates above 8% with stable or expanding margins. It would downgrade to a Sell if the stock breaks decisively below the $290 support level on worsening fundamentals. Based on current data, the stock appears fairly valued to slightly overvalued relative to its near-term growth prospects, but the long-term quality of the business prevents a more negative view.
Sign up to view all
SHW 12-Month Price Forecast
The outlook for SHW is one of high-quality stagnation. The company's fundamental strengths—its moat, cash flow, and dividend history—are undeniable, but they are currently overshadowed by cyclical headwinds and a premium valuation. The base case of range-bound trading is most probable, as the market awaits clearer signals on the demand cycle. The AI assessment is neutral with medium confidence, as the path forward is highly dependent on macroeconomic factors outside the company's control. The stance would upgrade to bullish on evidence of margin stabilization and re-accelerating top-line growth for two consecutive quarters. It would turn bearish if the stock breaks key support at $290 on high volume, signaling a loss of institutional conviction.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Sherwin-Williams's 12-month outlook, with a consensus price target around $403.72 and implied upside of +30.0% versus the current price.
Average Target
$403.72
9 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
9
covering this stock
Price Range
$248 - $404
Analyst target range
Analyst coverage is robust with 12 analysts providing estimates, and the institutional rating actions from firms like Mizuho, RBC Capital, and UBS consistently show 'Outperform' or 'Buy' ratings, indicating a bullish consensus sentiment. The average analyst revenue estimate for the coming period is $28.19 billion, with a high estimate of $28.65 billion and a low of $27.57 billion, while the average EPS estimate is $16.16, ranging from $15.70 to $16.50. The wide target price range implied by the EPS estimates, coupled with the recent reaffirmations of positive ratings despite the stock's decline, signals that analysts see current weakness as a buying opportunity but acknowledge uncertainty around the timing of a fundamental recovery. Insufficient specific price target data is provided to calculate a precise implied upside, but the sustained 'Buy' ratings from major institutions suggest the consensus views the stock as undervalued at current levels following its significant underperformance.
Bulls vs Bears: SHW Investment Factors
The investment debate for Sherwin-Williams is a classic clash between a high-quality, cash-generative business with a durable moat and the harsh reality of a cyclical slowdown pressuring its financials. Currently, the bearish evidence holds stronger sway, as the severe price decline (-17.15% YoY), significant margin compression, and decelerating revenue growth are concrete, recent data points. The bullish case rests on the company's long-term structural advantages and the expectation of a cyclical recovery, which is not yet visible in the reported numbers. The single most important tension is whether the company's premium valuation (31.08x trailing P/E) can be sustained or even expand in the face of slowing growth, or if further multiple compression is inevitable until a clear inflection in end-market demand materializes.
Bullish
- Dominant Market Position & Moat: Sherwin-Williams operates over 4,800 company-owned stores, creating a vertically integrated model that is difficult for competitors to replicate. This network provides a significant competitive moat, particularly in serving professional painters and contractors, which underpins its status as the global market leader.
- Strong Profitability & Cash Generation: The company maintains robust profitability metrics, with a trailing twelve-month free cash flow of $2.65 billion and a high Return on Equity of 55.86%. Even in a challenging Q4, it delivered a gross margin of 48.84% and a net margin of 8.52%, demonstrating financial resilience.
- Dividend Aristocrat with 47-Year Streak: The company recently declared its 47th consecutive annual dividend increase, reinforcing its exceptional financial discipline and commitment to shareholder returns. This track record provides a floor of income support for investors during periods of stock price volatility.
- Analyst Consensus Remains Bullish: Despite the stock's 17.15% annual decline, 12 covering analysts maintain a bullish consensus with 'Outperform' or 'Buy' ratings. This institutional support, including from firms like Mizuho and UBS, suggests the current weakness is viewed as a buying opportunity ahead of an expected earnings recovery.
Bearish
- Severe Technical Downtrend & Underperformance: The stock is in a pronounced downtrend, down 17.15% over the past year and trading just 3.1% above its 52-week low of $289.86. It has severely underperformed the SPY by -44.19% over the same period, indicating persistent selling pressure and negative momentum.
- Significant Revenue & Profitability Deceleration: Q4 2025 revenue growth slowed to 5.64% YoY, a deceleration from prior quarters. More critically, net margin compressed to 8.52% from 13.10% in Q3, and operating margin fell to 13.92%, indicating pressure on profitability from operating expenses.
- High Financial Leverage & Liquidity Risk: The company carries a high debt-to-equity ratio of 3.16, indicating aggressive use of debt financing. Furthermore, the current ratio of 0.87 suggests potential liquidity constraints in covering short-term obligations, which could be problematic in a prolonged downturn.
- Premium Valuation Despite Growth Slowdown: Even after its decline, SHW trades at a significant premium to industry peers, with a trailing P/E of 31.08x, a P/S of 3.39x, and an EV/EBITDA of 21.42x. This premium valuation is difficult to justify given the decelerating top-line growth of 5.64% in its latest quarter.
SHW Technical Analysis
The stock is in a pronounced downtrend, having declined 17.15% over the past year and currently trading at just 3.1% above its 52-week low of $289.86, positioning it near the bottom of its annual range which signals potential oversold conditions or fundamental deterioration. The price of $300.09 is far from the 52-week high of $379.65, and the 1-year price change of -17.15% coupled with a significant 6-month decline of -9.91% confirms the bearish momentum has been sustained over the medium term. Recent short-term momentum shows further weakness, with the stock down 3.96% over the past month and 9.03% over the past three months, a trend that aligns with and reinforces the longer-term downtrend rather than signaling a divergence or reversal. The stock's beta of 1.155 indicates it is approximately 16% more volatile than the broader market, which has compounded losses as evidenced by its severe relative underperformance of -44.19% against the SPY over the past year, making it a higher-risk proposition in the current environment. Key technical support is firmly established at the 52-week low of $289.86, while resistance lies at the recent highs near the 52-week high of $379.65; a sustained breakdown below the $290 support level would signal a new leg down, whereas a recovery above the descending trendline would require a significant catalyst.
Beta
1.13
1.13x market volatility
Max Drawdown
-21.9%
Largest decline past year
52-Week Range
$290-$380
Price range past year
Annual Return
-13.2%
Cumulative gain past year
| Period | SHW Return | S&P 500 |
|---|---|---|
| 1m | -2.0% | -0.1% |
| 3m | -3.8% | +9.0% |
| 6m | -5.7% | +7.0% |
| 1y | -13.2% | +22.9% |
| ytd | -5.3% | +8.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SHW Fundamental Analysis
Revenue growth has decelerated significantly, with the most recent Q4 2025 revenue of $5.60 billion representing a modest year-over-year increase of 5.64%, a slowdown from the stronger growth rates seen in prior quarters of 2025 such as Q3's $6.36 billion. Segment data reveals the Paint Stores Group, the largest segment at $3.13 billion, is the primary revenue driver, while the Consumer Group contributed $2.06 billion and the Global Finishes Group $1.65 billion, indicating reliance on the professional and architectural markets. The company remains profitable with Q4 2025 net income of $476.8 million, translating to a net margin of 8.52%, but profitability has compressed from the higher levels seen earlier in the year, such as the Q3 net margin of 13.10%. Gross margin for Q4 stood at 48.84%, which is healthy for the industry, but operating income of $778.7 million yields an operating margin of 13.92%, showing pressure from operating expenses which totaled $1.95 billion in the quarter. The balance sheet carries significant financial leverage with a debt-to-equity ratio of 3.16, indicating aggressive use of debt financing, though the company generates substantial cash flow with trailing twelve-month free cash flow of $2.65 billion. Return on equity is exceptionally high at 55.86%, a function of both strong profitability and high financial leverage, while the current ratio of 0.87 suggests potential liquidity constraints in covering short-term obligations.
Quarterly Revenue
$5.6B
2025-12
Revenue YoY Growth
+0.05%
YoY Comparison
Gross Margin
+0.48%
Latest Quarter
Free Cash Flow
$2.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SHW Overvalued?
Given the company's consistent profitability with positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE ratio is elevated at 31.08x, while the forward PE is notably lower at 22.70x, indicating the market expects a meaningful recovery in earnings over the next twelve months. Compared to industry averages, Sherwin-Williams trades at a significant premium; its trailing PE of 31.08x is well above typical specialty chemical peers, and its Price-to-Sales ratio of 3.39x and EV/EBITDA of 21.42x also suggest a premium valuation justified by its market-leading position and strong brand. Historically, the current trailing PE of 31.08x sits below the stock's own recent historical highs seen in Q1 2025 (43.21x) and Q4 2024 (44.73x), but remains above the lower end of its multi-year range observed in 2022 and 2023, suggesting the valuation has compressed but may not yet be at bargain levels relative to its own history.
PE
31.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~75x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
21.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Sherwin-Williams faces significant financial risk from its highly leveraged balance sheet, with a debt-to-equity ratio of 3.16. This aggressive capital structure amplifies risks during a downturn, as seen in the Q4 net margin compression from 13.10% to 8.52%. Operational risks include revenue concentration in the cyclical Paint Stores Group ($3.13B in Q4) and sensitivity to housing and industrial markets, evidenced by the slowdown in revenue growth to 5.64% YoY. The current ratio of 0.87 indicates potential short-term liquidity constraints, though substantial TTM FCF of $2.65B provides some cushion.
Market & Competitive Risks: The primary market risk is valuation compression. Despite its decline, SHW trades at a premium to peers (P/E 31.08x, EV/EBITDA 21.42x). If growth continues to decelerate, this premium could contract further. The stock's beta of 1.155 makes it 16% more volatile than the market, which has led to severe relative underperformance (-44.19% vs. SPY). Competitive risks are moderated by its vast store network, but a prolonged economic slump could pressure pricing and market share. Recent news highlights its dividend discipline but does not offset the overarching demand concerns.
Worst-Case Scenario: The worst-case scenario involves a deepening recession in key end-markets (housing, industrial), leading to a sustained decline in volumes and pricing power. This would trigger further margin compression, potentially pushing net margins below 5%, and could strain the company's ability to service its high debt load comfortably. A breakdown of investor confidence in the 'quality premium' could lead to a re-rating towards industry-average multiples. Realistic downside could see the stock retesting and breaking its 52-week low of $289.86, implying a potential loss of approximately -3.4% from the current $300.09. A more severe bear case, aligning with the stock's recent max drawdown of -21.91%, suggests a potential decline to the $235-$240 range, representing a loss of over -20%.
FAQ
The key risks are: 1) Financial Risk: High debt-to-equity ratio (3.16) and a weak current ratio (0.87) amplify downside in a downturn. 2) Cyclical Demand Risk: Revenue is heavily exposed to housing and industrial markets, which are currently soft (5.64% Q4 growth). 3) Valuation Risk: Premium multiples (P/E 31.08x) could compress further if growth slows. 4) Operational Risk: Recent sharp margin compression (Q4 net margin 8.52% vs. Q3 13.10%) indicates vulnerability to rising costs and weak volumes. The cyclical demand risk is currently the most severe, as it directly pressures the financial metrics.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $330 and $360, as end-markets stabilize and the company executes on its forward EPS estimate of $16.16. The Bull Case (25% probability) targets $379-$400 on a strong cyclical recovery and multiple expansion. The Bear Case (15% probability) warns of a retest of the $290-$310 range if the economic slowdown worsens. The Base Case is most likely, hinging on the assumption that the current downturn is moderate and does not escalate into a deep recession.
SHW stock appears fairly valued to slightly overvalued based on its near-term prospects. Its trailing P/E of 31.08x and EV/EBITDA of 21.42x represent a significant premium to the specialty chemicals industry average, justified by its superior margins and market position. However, this premium is being tested by decelerating growth. The forward P/E of 22.70x suggests the market is pricing in an earnings recovery. The valuation implies the market expects a cyclical rebound; if that rebound is delayed, the stock could be overvalued.
SHW is a good buy for long-term, patient investors who believe in its market-leading position and are willing to wait out the current cyclical downturn. The stock offers a 1% dividend yield backed by 47 consecutive years of increases. However, with revenue growth slowing to 5.64% and the stock trading at a premium forward P/E of 22.70x, the near-term risk/reward is not compelling for tactical investors. It becomes a more attractive buy if the price approaches the $290 support level, offering a better margin of safety.
SHW is unequivocally suitable for long-term investment, not short-term trading. Its value proposition is built over decades through its store network, brand, and dividend history. The stock's high beta (1.155) and sensitivity to economic cycles make it volatile and unpredictable in the short term, as evidenced by its -17.15% annual decline. Long-term investors can benefit from the company's durable moat and compounding dividends. A minimum holding period of 3-5 years is suggested to ride through the industry cycle and capture the full value of the business.